Ornithine transcarbamylase deficiency, a highly common urea cycle disorder and rare X-linked genetic disorder, is characterized by partial or a complete lack of enzyme ornithine transcarbamylase (OTC)
Wilmington, Delaware, United States, Transparency Market Research Inc. – Ornithine transcarbamylase deficiency, a highly common urea cycle disorder and rare X-linked genetic disorder, is characterized by partial or a complete lack of enzyme ornithine transcarbamylase (OTC)
OTC is one of six enzymes that play a role in breakdown and removal of nitrogen in the body, a process known as the urea cycle
Read Report Overview – https://www.transparencymarketresearch.com/ornithine-transcarbamylase-otc-deficiency-treatment-market.html
OTC deficiency is a genetic disorder characterized by a complete or partial lack of the enzyme ornithine transcarbamylase (OTC). It is an abnormal gene on the X chromosome and manifests mostly in males.
Both males and females may develop symptoms of OTC deficiency during childhood. Females who have a defective gene present on one of their X chromosomes are carriers for the disorder.
Request Sample of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=78569
Ornithine Transcarbamylase (OTC) Deficiency Treatment Market: Drivers
- Rising prevalence of OTC deficiency and development of new therapies for the treatment of OTC deficiency are major factors boosting the global ornithine transcarbamylase (OTC) deficiency treatment market
- For instance, according to Orphanet, the estimated prevalence of ornithine transcarbamylase deficiency ranges between 1/56,500 and 1/113,000 live births across the world
- Favorable reimbursement scenario and patient assistance programs provided by various international as well as regional organizations are also major drivers of the global Ornithine Transcarbamylase (OTC) deficiency treatment market
- Patient compliance is affected due to bitter taste and foul odor of products. Hence, research and development is being carried out to develop new formulations of this drug in order to overcome such serious issues.
- Consequently, formulation modification for better patient compliance also propels the global ornithine transcarbamylase (OTC) deficiency treatment market
Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=78569
Market Segmentation: Ornithine Transcarbamylase (OTC) Deficiency Treatment Market
- In terms of product, the global ornithine transcarbamylase (OTC) deficiency treatment market has been divided into Buphenyl, Ravicti, Ammonul, dietary supplements, and others
- Based on route of administration, the global ornithine transcarbamylase (OTC) deficiency treatment market has been bifurcated into oral and intravenous
- In terms of distribution channel, the global ornithine transcarbamylase (OTC) deficiency treatment market has been segmented into hospital pharmacies, retail pharmacies, and online pharmacies
- Each of the ornithine transcarbamylase (OTC) deficiency treatment market segments has been analyzed in detail for market trends, recent trends and developments, drivers, restraints, opportunities, and useful insights
- The ornithine transcarbamylase (OTC) deficiency treatment market report provides current and future revenues (US$ Mn) for each of the segments for the period from 2018 to 2030, considering 2019 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2020 to 2030 along with market size estimations.
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=78569
Regional Overview: Ornithine Transcarbamylase (OTC) Deficiency Treatment Market
- In terms of region, the global ornithine transcarbamylase (OTC) deficiency treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
- North America dominated the global ornithine transcarbamylase (OTC) deficiency treatment market in 2019, and the trend is projected to continue during the forecast period
- The current and future sizes of the ornithine transcarbamylase (OTC) deficiency treatment market, in terms of value (US$ Mn), of regional markets and their major countries have been provided in the report for the period from 2018 to 2030, along with their CAGRs for the period from 2020 to 2030
- The study also offers a list of recommendations, highlights, and useful insights of the market, which would help new companies willing to enter the market and existing companies to increase market shares and help in the decision-making process
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=78569
Major Players
The ornithine transcarbamylase (OTC) deficiency treatment market report concludes with the company profiles section that includes key information about the major players in the market
Key players analyzed in the ornithine transcarbamylase (OTC) deficiency treatment market report are -
- Abbott
- Nutricia (Danone Group)
- Mead Johnson (Reckitt Benckiser)
- Horizon Therapeutics plc
- Nestlé
- Bausch Health Companies, Inc.
- Ultragenyx Pharmaceutical Inc.
- Arcturus Therapeutics, Inc.
- Acer Therapeutics
Each of these players has been profiled in the global ornithine transcarbamylase (OTC) deficiency treatment market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
More Trending Reports by Transparency Market Research –
Healthcare Contract Research Outsourcing Market: The global healthcare contract research outsourcing market is expected to reach the value of US$ 63.09 Bn by the end of 2028.
Healthcare Biometrics Market: The global healthcare biometrics market is expected to reach the value of US$ 74.08 Bn by the end of 2028.
Cloud Computing Market: The global cloud computing market in healthcare industry is expected to reach the value of US$ 911.6 Bn by the end of 2028.
Population Health Management Market: The global population health management market is expected to cross the value of US$ 86.9 Bn by the end of 2028.
Medical Transcription Services Market: The global medical transcription services market is expected to cross the value of US$ 96.7 Bn by the end of 2028.
Corporate Wellness Market: The global corporate wellness market is expected to cross the value of US$ 74.5 Bn by the end of 2028.
3D Printing in Medical Applications Market: The global 3D printing in medical application market is expected to cross the value of US$ 2.76 Bn by the end of 2028.
Dura Substitute Market: The global dura substitute market is expected to reach the value of US$ 328.6 Mn by the end of 2031.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com